Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home 2024
Archives
Identifying potential exercise mimetics that deliver the benefits of exercise
Robert Wessells, Associate Professor at Wayne State University, discusses his research on identifying potential exercise mediators or mimetics to deliver the benefits of exercise to less mobile individuals and help reduce the global disease burden.
Persistent anti-vaxxers and pandemic-induced new anti-vaxxers
Read this analysis of persistent anti-vaxxers and pandemic-induced new anti-vaxxers by Fujio Toriumi, Professor at the University of Tokyo in Japan.
Tuning into musicians’ wellbeing: Research on music performance anxiety (MPA)
The Music and Mental Health Research Clinic (MMHRC) at the University of Ottawa’s Institute of Mental Health Research (IMHR) at The Royal is investigating how to reduce music performance anxiety (MPA) and the benefits of specific coping strategies for musicians.
Harnessing hybrid molecules for drug development
Stoyanka Nikolova, Professor from Paisii Hilendarski Plovdiv University, discusses the potential of harnessing hybrid molecules for drug development and their possible application in addressing the clinical challenge of irritable bowel syndrome.
Early intervention in eating disorders
Tracey Wade from Flinders University, charts an implementation approach to early intervention in eating disorders.
A game that poses a challenge to artificial intelligence
Steven J. Brams, hailing from New York University, unveils a game that poses a challenge to artificial intelligence.
A promising approach to preventing developmental dyslexia
David Mather, an Independent Researcher at the University of Victoria, has a promising approach to preventing developmental dyslexia. Discover more here.
Innovative packaging design enhances vaccine accessibility for developing countries
Unither Pharmaceuticals is dedicated to innovating and expanding capacity to provide equitable vaccine accessibility in developing countries and enhance preparedness for future pandemics. Here, they explain how the Euroject® device can support their goals.
Healthy aging: A novel therapy to reverse age-related damage
What if we could turn back the clock on age-associated dysfunctions by using a therapy that not only treats symptoms but acts to correct the underlying pathology and restores cells to normal function? Lori A. Birder and Edwin K. Jackson from the University of Pittsburgh School of Medicine, explain how this could be a possibility.
Flipons: The discovery of Z-DNA and soft-wired genomes
Alan Herbert, Founder and President of InsideOutBio, discusses alternative DNA conformations and understanding of their biological functions.
The impact of juvenile onset rheumatic and musculoskeletal diseases on education, vocation and employment
Professor Suzanne Verstappen discusses the impact and challenges associated with juvenile-onset rheumatic and musculoskeletal diseases when navigating education and employment.
How the dark genome enlightens the molecular mechanisms of diseases
In this article, Antoinette van Ouwerkerk and Salvatore Spicuglia from INSERM highlight the significance of regulatory variants within the non-coding genome – often referred to as the ‘dark genome’ – in influencing gene expression and disease.
![Figure 1: a) Nanotextured spinal implants now in over 30,000 humans with no cases of failure [2]. Such implants are being commercialized by Nanovis. b) Nanosensors now being used to detect the presence of bacteria, inflammatory cells, or bone-forming cells on implants. Such nanosensors can communicate to handheld devices and can respond in real-time to reverse adverse events. Such sensors have been implanted in sheep for up to 12 weeks showing the ability to promote bone growth.](https://www.openaccessgovernment.org/wp-content/uploads/2024/07/Screenshot-2024-07-04-at-09.19.27-218x150.png "Opinion: What are the barriers to innovation in medicine?")
Opinion: What are the barriers to innovation in medicine?
Thomas J. Webster, PhD provides a firsthand account of the obstacles hindering innovation in medicine, covering publishing, conferences, politics, funding, universities, and industry.
The future of AVS, dizziness, and vertigo in emergency departments Part iii: A tyranny...
In the third article of this five-part series, Dr Millie Nakatsuka discusses the impact of isolation on health equity and the medical decision-making for emergency presentations of acute vestibular syndrome (AVS)
The challenge of generating lasting mucosal anti-viral sterilising immunity
Achieving sterilising immunity is often challenging and sometimes even impossible. This article gives a glimpse into the concepts behind and highlights some recent advances and challenges.
The role of stem cell-derived tissues in novel treatments for cardiac ailments
Curbs on animal testing mean human tissues derived from induced pluripotent stem cells offer a promising platform in discovering novel treatments for cardiac ailments.
Safer and more effective use of opioids
The Pain PLUS literature surveillance service demonstrates the importance of high-quality literature to support decision-making and practice for the use of opioids.
Predicting cochlear implant performance: Impact of demographic, audiologic, surgical factors, and cochlear health
Amit Walia, Matt Shew and Craig A. Buchman from Washington University School of Medicine, explain the challenges of understanding variables or factors informing CI performance and how this can be addressed.
Artificial intelligence (AI) in mammographic screening in Norway
BreastScreen Norway discusses how the results from their screening programme for early breast cancer detection can influence future artificial intelligence to streamline early breast cancer detection.
Innovation in clinical trials in brain health: Computerised assessment and remote clinical trials
New clinical trials in brain health require innovative methodologies for targeted recruitment and longitudinal assessment. Professor Anne Corbett outlines how her team’s PROTECT portfolio can overcome challenges in trials of cognitive health interventions, offering solutions for intelligent trial design.
